Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.

ESPR

Esperion Therapeutics (ESPR)

Esperion Therapeutics Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:ESPR
DateTimeSourceHeadlineSymbolCompany
04/04/20224:03PMEdgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)NASDAQ:ESPREsperion Therapeutics Inc
04/04/20226:18AMTipRanksH.C. Wainwright Reiterates Their Buy Rating on Esperion (ESPR)NASDAQ:ESPREsperion Therapeutics Inc
04/03/202212:00PMGlobeNewswire Inc.Esperion Announces Two NEXLETOL® (bempedoic acid) Data Presentations at the American College of Cardiology’s 71st Annual Scientific Session & ExpoNASDAQ:ESPREsperion Therapeutics Inc
03/29/20228:00AMGlobeNewswire Inc.Esperion to Participate in Upcoming 21st Annual Needham Virtual Healthcare ConferenceNASDAQ:ESPREsperion Therapeutics Inc
03/16/20225:11PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ESPREsperion Therapeutics Inc
03/16/20225:10PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ESPREsperion Therapeutics Inc
03/16/20225:09PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ESPREsperion Therapeutics Inc
03/15/20224:01PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ESPREsperion Therapeutics Inc
03/09/20224:54PMEdgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:ESPREsperion Therapeutics Inc
02/24/20228:00AMGlobeNewswire Inc.Esperion to Participate in Upcoming Virtual Cowen 42nd Annual Healthcare ConferenceNASDAQ:ESPREsperion Therapeutics Inc
02/22/20229:14AMEdgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:ESPREsperion Therapeutics Inc
02/22/20229:05AMEdgar (US Regulatory)Annual Report (10-k)NASDAQ:ESPREsperion Therapeutics Inc
02/22/20227:31AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ESPREsperion Therapeutics Inc
02/22/20227:00AMGlobeNewswire Inc.Esperion Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Company UpdateNASDAQ:ESPREsperion Therapeutics Inc
02/14/20223:20PMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:ESPREsperion Therapeutics Inc
02/11/20224:14PMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:ESPREsperion Therapeutics Inc
02/11/20222:56PMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:ESPREsperion Therapeutics Inc
02/08/20228:00AMGlobeNewswire Inc.Esperion to Report Fourth Quarter and Full Year 2021 Financial Results February 22, 2022NASDAQ:ESPREsperion Therapeutics Inc
01/28/20225:08PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ESPREsperion Therapeutics Inc
01/28/20225:00PMGlobeNewswire Inc.Esperion Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)NASDAQ:ESPREsperion Therapeutics Inc
01/12/20222:16PMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:ESPREsperion Therapeutics Inc
01/11/20225:25PMTipRanksEsperion (ESPR) Gets a Buy Rating from NeedhamNASDAQ:ESPREsperion Therapeutics Inc
01/11/20228:00AMGlobeNewswire Inc.Esperion Provides Preliminary Fourth Quarter 2021 Financial Results and CLEAR Outcomes Program UpdateNASDAQ:ESPREsperion Therapeutics Inc
01/10/202212:56PMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:ESPREsperion Therapeutics Inc
01/06/20228:00AMGlobeNewswire Inc.Esperion to Participate in Upcoming Virtual J.P. Morgan 40th Annual Healthcare ConferenceNASDAQ:ESPREsperion Therapeutics Inc
01/04/20228:42AMEdgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:ESPREsperion Therapeutics Inc
01/04/20228:29AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ESPREsperion Therapeutics Inc
01/04/20228:00AMGlobeNewswire Inc.Esperion Appoints Benjamin O. Looker as General CounselNASDAQ:ESPREsperion Therapeutics Inc
12/23/20217:05AMTipRanksAnalysts Offer Insights on Healthcare Companies: Esperion (ESPR) and CytomX Therapeutics (CTMX)NASDAQ:ESPREsperion Therapeutics Inc
12/10/202112:19PMEdgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:ESPREsperion Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:ESPR

Your Recent History

Delayed Upgrade Clock